CG Oncology, Inc. Research And Development Expense

Quick Answer

CG Oncology, Inc. reported Research And Development Expense of $116.64 million for the year ending 2025.

  • CG Oncology, Inc. showed an increase of +42.1% in Research And Development Expense from 2024 to 2025.
  • This data is from CG Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2025), CG Oncology, Inc.'s Research And Development Expense has grown by 154.9%.
  • Historical annual values: Fiscal year 2025: $116.64 million | Fiscal year 2024: $82.10 million | Fiscal year 2023: $45.75 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: